DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

عرض إصدارات أخرى (1)

Mutations in DOK7 are a common cause of congenital myasthenia. Treatment with ephedrine or salbutamol is effective, but diagnosis is often delayed. The aim of our study was to find early clues to the diagnosis of DOK7 congenital myasthenic syndrome. We included 23 children of 20 families. Onset of s...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Klein, A, Pitt, M, McHugh, J, Niks, E, Sewry, C, Phadke, R, Feng, L, Manzur, A, Tirupathi, S, DeVile, C, Jayawant, S, Finlayson, S, Palace, J, Muntoni, F, Beeson, D, Robb, SA
التنسيق:	Journal article
اللغة:	English
منشور في:	2013

مواد مشابهة

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
حسب: Klein, A, وآخرون
منشور في: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
حسب: Burke, G, وآخرون
منشور في: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
حسب: Lashley, D, وآخرون
منشور في: (2010)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
حسب: Jephson, C, وآخرون
منشور في: (2010)

DOK7 congenital myasthenic syndrome.
حسب: Palace, J
منشور في: (2012)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
حسب: Kinali, M, وآخرون
منشور في: (2008)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
حسب: Cossins, J, وآخرون
منشور في: (2012)

Congenital myasthenic syndromes: an update.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
حسب: Yamanashi, Y, وآخرون
منشور في: (2008)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
حسب: Lashley, D, وآخرون
منشور في: (2009)

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
حسب: Müller, J, وآخرون
منشور في: (2007)

DOK7 Mutations in Congenital Myasthenic Syndromes
حسب: J Gordon Millichap
منشور في: (2007-06-01)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
حسب: Beeson, D, وآخرون
منشور في: (2012)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
حسب: Lashley, D, وآخرون
منشور في: (2009)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
حسب: Burke, G, وآخرون
منشور في: (2006)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
حسب: Palace, J, وآخرون
منشور في: (2007)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
حسب: Finlayson, S, وآخرون
منشور في: (2016)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
حسب: Beeson, D, وآخرون
منشور في: (2006)

The congenital myasthenic syndromes.
حسب: Palace, J, وآخرون
منشور في: (2008)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
حسب: Cossins, J, وآخرون
منشور في: (2010)

Congenital myasthenic syndromes.
حسب: Beeson, D, وآخرون
منشور في: (1997)

DOK7 congenital myasthenic syndrome: case series and review of literature
حسب: Bentolhoda Ziaadini, وآخرون
منشور في: (2024-06-01)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
حسب: Finlayson, S, وآخرون
منشور في: (2012)

Congenital myasthenic syndromes and the neuromuscular junction.
حسب: Cruz, P, وآخرون
منشور في: (2014)

Therapeutic strategies for congenital myasthenic syndromes
حسب: Lee, M, وآخرون
منشور في: (2018)

Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
حسب: Clausen, L
منشور في: (2015)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
حسب: Jorge A. Bevilacqua, وآخرون
منشور في: (2017-09-01)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
حسب: Healy, E, وآخرون
منشور في: (2014)

Congenital myasthenic syndrome caused by mutations in DPAGT.
حسب: Klein, A, وآخرون
منشور في: (2015)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
حسب: Belaya, K, وآخرون
منشور في: (2012)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
حسب: Rodríguez Cruz, P, وآخرون
منشور في: (2018)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
حسب: Finlayson, S, وآخرون
منشور في: (2013)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
حسب: Mewasingh, L, وآخرون
منشور في: (2006)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
حسب: Chaouch, A, وآخرون
منشور في: (2012)

Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
حسب: Munot, P, وآخرون
منشور في: (2010)

Therapy of myasthenic syndrome
حسب: Palace, J
منشور في: (2012)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
حسب: Palace, J
منشور في: (2010)

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
حسب: Hamuro, J, وآخرون
منشور في: (2008)